Dual-Energy Micro-CT Functional Imaging of Primary Lung Cancer in Mice Using Gold and Iodine Nanoparticle Contrast Agents: A Validation Study

Purpose To provide additional functional information for tumor characterization, we investigated the use of dual-energy computed tomography for imaging murine lung tumors. Tumor blood volume and vascular permeability were quantified using gold and iodine nanoparticles. This approach was compared with a single contrast agent/single-energy CT method. Ex vivo validation studies were performed to demonstrate the accuracy of in vivo contrast agent quantification by CT. Methods Primary lung tumors were generated in LSL-KrasG12D; p53FL/FL mice. Gold nanoparticles were injected, followed by iodine nanoparticles two days later. The gold accumulated in tumors, while the iodine provided intravascular contrast. Three dual-energy CT scans were performed–two for the single contrast agent method and one for the dual contrast agent method. Gold and iodine concentrations in each scan were calculated using a dual-energy decomposition. For each method, the tumor fractional blood volume was calculated based on iodine concentration, and tumor vascular permeability was estimated based on accumulated gold concentration. For validation, the CT-derived measurements were compared with histology and inductively-coupled plasma optical emission spectroscopy measurements of gold concentrations in tissues. Results Dual-energy CT enabled in vivo separation of gold and iodine contrast agents and showed uptake of gold nanoparticles in the spleen, liver, and tumors. The tumor fractional blood volume measurements determined from the two imaging methods were in agreement, and a high correlation (R2 = 0.81) was found between measured fractional blood volume and histology-derived microvascular density. Vascular permeability measurements obtained from the two imaging methods agreed well with ex vivo measurements. Conclusions Dual-energy CT using two types of nanoparticles is equivalent to the single nanoparticle method, but allows for measurement of fractional blood volume and permeability with a single scan. As confirmed by ex vivo methods, CT-derived nanoparticle concentrations are accurate. This method could play an important role in lung tumor characterization by CT.

[1]  G. Frens.  Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions , 1973 .

[2]  L. Feldkamp,et al.  Practical cone-beam algorithm , 1984 .

[3]  P. Jolliet,et al.  An Overview of the Clinical Pharmacokinetics of X-Ray Contrast Media , 1997, Clinical pharmacokinetics.

[4]  T. Jacks,et al.  Somatic activation of the K-ras oncogene causes early onset lung cancer in mice , 2001, Nature.

[5]  H. Maeda.  The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. , 2001, Advances in enzyme regulation.

[6]  J. Verdebout,et al.  The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis , 2002, British Journal of Cancer.

[7]  Olivier D. Faugeras,et al.  Variational Methods for Multimodal Image Matching , 2002, International Journal of Computer Vision.

[8]  L. Hedlund,et al.  Micro-CT with respiratory and cardiac gating. , 2004, Medical physics.

[9]  T. Jacks,et al.  The differential effects of mutant p53 alleles on advanced murine lung cancer. , 2005, Cancer research.

[10]  U. Tateishi.  Vascular endothelial growth factor-related angiogenesis. , 2005, Radiology.

[11]  L. Hedlund,et al.  A liposomal nanoscale contrast agent for preclinical CT in mice. , 2006, AJR. American journal of roentgenology.

[12]  S. Markowitz,et al.  Ability of low-dose helical CT to distinguish between benign and malignant noncalcified lung nodules. , 2007, Chest.

[13]  D. Fernig,et al.  Determination of size and concentration of gold nanoparticles from UV-vis spectra. , 2007, Analytical chemistry.

[14]  Ming De Lin,et al.  A dual micro-CT system for small animal imaging , 2008, SPIE Medical Imaging.

[15]  Xiao-Cheng Wu,et al.  Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control , 2008, Journal of the National Cancer Institute.

[16]  R. Bellamkonda,et al.  Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. , 2009, Radiology.

[17]  Efstathios Karathanasis,et al.  Tumor Vascular Permeability to a Nanoprobe Correlates to Tumor-Specific Expression Levels of Angiogenic Markers , 2009, PloS one.

[18]  Warren C W Chan,et al.  Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.

[19]  David A Jaffray,et al.  Liposome contrast agent for CT-based detection and localization of neoplastic and inflammatory lesions in rabbits: validation with FDG-PET and histology. , 2010, Contrast media & molecular imaging.

[20]  John A Kalef-Ezra,et al.  Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma , 2010, Physics in medicine and biology.

[21]  Bradley Duncan,et al.  Gold nanoparticle platforms as drug and biomacromolecule delivery systems. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Y. Jeong,et al.  A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. , 2010, ACS nano.

[23]  R. Cardiff,et al.  Longitudinal Investigation of Permeability and Distribution of Macromolecules in Mouse Malignant Transformation Using PET , 2010, Clinical Cancer Research.

[24]  Axel Thran,et al.  Note: This Copy Is for Your Personal, Non-commercial Use Only. to Order Presentation-ready Copies for Distribution to Your Colleagues or Clients, Contact Us at Www.rsna.org/rsnarights. Atherosclerotic Plaque Composition: Analysis with Multicolor Ct and Targeted Gold Nanoparticles 1 Materials and Met , 2022 .

[25]  T. Jacks,et al.  Imaging primary lung cancers in mice to study radiation biology. , 2010, International journal of radiation oncology, biology, physics.

[26]  Arno Klein,et al.  A reproducible evaluation of ANTs similarity metric performance in brain image registration , 2011, NeuroImage.

[27]  Cristian T. Badea,et al.  Dual-energy micro-CT imaging for differentiation of iodine- and gold-based nanoparticles , 2011, Medical Imaging.

[28]  J F Hainfeld,et al.  Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions. , 2011, The British journal of radiology.

[29]  Lei Xu,et al.  Normalization of the vasculature for treatment of cancer and other diseases. , 2011, Physiological reviews.

[30]  S. Wildermuth,et al.  Dual- and multi-energy CT: approach to functional imaging , 2011, Insights into imaging.

[31]  Nastassja A. Lewinski,et al.  A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies. , 2011, Small.

[32]  P. Prorok,et al.  Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST) , 2011, Journal of medical screening.

[33]  Thomas Henzler,et al.  Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT? , 2011, European Radiology.

[34]  S M Johnston,et al.  Dual-energy micro-CT of the rodent lung. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[35]  G. Allan Johnson,et al.  Denoising of 4D cardiac micro-CT data using median-centric bilateral filtration , 2012, Medical Imaging.

[36]  J. Ko,et al.  Evaluation and management of indeterminate pulmonary nodules. , 2012, Radiologic clinics of North America.

[37]  Thorsten Fleiter,et al.  Syntheses and characterization of lisinopril-coated gold nanoparticles as highly stable targeted CT contrast agents in cardiovascular diseases. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[38]  G. Allan Johnson,et al.  Computed Tomography Imaging of Primary Lung Cancer in Mice Using a Liposomal-Iodinated Contrast Agent , 2012, PloS one.

[39]  P. Kee,et al.  CT imaging of myocardial scars with collagen-targeting gold nanoparticles. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[40]  C. Badea,et al.  In vivo characterization of tumor vasculature using iodine and gold nanoparticles and dual energy micro-CT , 2013, Physics in medicine and biology.

[41]  G Allan Johnson,et al.  Dual-energy micro-computed tomography imaging of radiation-induced vascular changes in primary mouse sarcomas. , 2013, International journal of radiation oncology, biology, physics.

[42]  Efstathios Karathanasis,et al.  Multimodal in vivo imaging exposes the voyage of nanoparticles in tumor microcirculation. , 2013, ACS nano.

[43]  Valerie A Longo,et al.  Gold nanoparticles provide bright long-lasting vascular contrast for CT imaging. , 2013, AJR. American journal of roentgenology.

[44]  Robert N. Anderson,et al.  Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels , 2013, Journal of the National Cancer Institute.

[45]  Dongsheng Liu,et al.  Efficient, pH‐Triggered Drug Delivery Using a pH‐Responsive DNA‐Conjugated Gold Nanoparticle , 2013, Advanced healthcare materials.

[46]  Yi Qi,et al.  Anatomical and functional imaging of myocardial infarction in mice using micro-CT and eXIA 160 contrast agent. , 2014, Contrast media & molecular imaging.